J7198 HCPCS Level II code: Anti-inhibitor, per i.u.
J7198 is the HCPCS code for “Anti-inhibitor, per i.u.” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J7198Anti-inhibitor, per i.u.
Short description: Anti-inhibitor
HCPCS · United States
Medicare details
The indicators CMS publishes with J7198 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 2000
Where J7198 sits
- 1J codesDrugs administered other than orally
- 2Active code J7198Anti-inhibitor, per i.u.
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J7198 mean?
J7198 is the HCPCS code for “Anti-inhibitor, per i.u.” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J7198?
CMS lists J7198’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J7198
All J codesJ7192Factor viii (antihemophilic factor, recombinant) per i.u., not otherwise specifiedJ7193Factor ix (antihemophilic factor, purified, non-recombinant) per i.u.J7194Factor ix, complex, per i.u.J7195Injection, factor ix (antihemophilic factor, recombinant) per iu, not otherwise specifiedJ7196Injection, antithrombin recombinant, 50 i.u.J7197Antithrombin iii (human), per i.u.J7199Hemophilia clotting factor, not otherwise classifiedJ7200Injection, factor ix, (antihemophilic factor, recombinant), rixubis, per iuJ7201Injection, factor ix, fc fusion protein, (recombinant), alprolix, 1 i.u.J7202Injection, factor ix, albumin fusion protein, (recombinant), idelvion, 1 i.u.J7203Injection factor ix, (antihemophilic factor, recombinant), glycopegylated, (rebinyn), 1 iuJ7204Injection, factor viii, antihemophilic factor (recombinant), (esperoct), glycopegylated-exei, per iu